GlassScriptPhysician profile
Roger A Williams
NPI 1568572709
$7,120.35
in general payments reported to CMS, 2019-2025
51 companies · $1,450 in 2025
The $1,450 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,257 · 2020: $531 · 2021: $876 · 2022: $977 · 2023: $1,036 · 2024: $993 · 2025: $1,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,479.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $670.71 | 2019-2025 | Xience Sierra, Navitor, Confirm Rx |
| Medtronic, INC. | $568.80 | 2023-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Boston Scientific Corporation | $560.47 | 2020-2025 | General - Vascular Intervention, Watchman Flx, Cds - Mct/Cem Monitoring |
| Penumbra, INC. | $493.84 | 2021-2025 | Indigo System |
| Thrombolex, INC. | $401.71 | 2024-2025 | Bashir Endovascular Catheter |
| Abiomed | $308.70 | 2021-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $298.95 | 2019-2025 | |
| Philips North America LLC | $274.97 | 2022-2025 | Coronary Other |
| Biotronik INC. | $240.64 | 2019 | |
| Janssen Pharmaceuticals, INC | $234.26 | 2019-2024 | Xarelto |
| Angiodynamics, INC. | $224.12 | 2022 | |
| Pfizer INC. | $217.17 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $212.65 | 2019-2025 | Amvuttra, Onpattro |
| Cook Medical LLC | $195.32 | 2020-2023 | Zilver Ptx |
| Merck Sharp & Dohme LLC | $182.48 | 2021-2024 | Verquvo |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $158.03 | 2019-2024 | Lutonix Drug Coated Balloon |
| Amgen INC. | $156.33 | 2020-2025 | Repatha, Repatha |
| Amarin Pharma, INC. | $141.09 | 2019-2021 | |
| Inari Medical, INC. | $136.06 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.16 | 2019-2024 | Jardiance |
| Livanova USA, INC. | $125.67 | 2021 | |
| Ekos Corporation | $98.23 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $94.59 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $85.04 | 2019-2023 | Eliquis |
| Medtronic Vascular, INC. | $84.43 | 2020 | |
| Janssen Scientific Affairs, LLC | $79.96 | 2019 | |
| Celonova Biosciences, INC. | $63.96 | 2019 | |
| Cardiva Medical, INC. | $60.85 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Irhythm Technologies, INC. | $58.00 | 2019-2022 | |
| Heartflow, INC. | $51.73 | 2022 | |
| Shockwave Medical, INC | $51.43 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.96 | 2019-2025 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $33.91 | 2019 | |
| Cordis US Corp. | $33.48 | 2025 | Mynx Control |
| Daiichi Sankyo INC. | $32.49 | 2020 | |
| Chiesi USA, INC. | $32.12 | 2019-2021 | |
| Esperion Therapeutics, INC. | $31.15 | 2020-2025 | Nexletol |
| Impulse Dynamics (USA) INC. | $29.11 | 2022-2023 | Optimizer |
| W. L. Gore & Associates, INC. | $25.00 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Novo Nordisk INC | $22.39 | 2025 | Wegovy |
| Glaxosmithkline, LLC. | $21.88 | 2025 | Shingrix, Arexvy |
| Edwards Lifesciences Corporation | $21.54 | 2023 | Sapien 3 Ultra Resilia |
| Nuwellis, INC. | $19.92 | 2024 | Aquadex Smartflow Console |
| Sobi, INC | $16.44 | 2022 | |
| Scpharmaceuticals INC. | $15.90 | 2024 | |
| Astellas Pharma US INC | $15.26 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Endologix LLC | $14.52 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $13.97 | 2023 | Inpefa |
| Bracco Diagnostics INC. | $13.47 | 2023 | |
| Akcea Therapeutics, INC. | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.